Xiang-Hui Ning

Xiang-Hui Ning

Auto-generated profile, based on publicly available information

Xiang-Hui Ning

Department of Urology

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
TLTeng Li
Teng Li
Jinchao ChenJinchao Chen
Jinchao Chen
YJYuan Jiang
Yuan Jiang
XNXianghui Ning
Xianghui Ning
SPShuanghe Peng
Shuanghe Peng
KGKan Gong
Kan Gong

14 July 2014 in Cancer Research
Verified
Journal Article
Open access
PDF file
XNXiang-Hui Ning
Xiang-Hui Ning
NZNing Zhang
Ning Zhang
TLTeng Li
Teng Li
PWPeng-Jie Wu
Peng-Jie Wu
XWXi Wang
Xi Wang
KGKan Gong
Kan Gong
Von Hippel–Lindau (VHL) disease is a rare autosomal dominant cancer syndrome. A phenomenon known as genetic anticipation has been documented in some hereditary cancer syndromes, where it was proved to relate to telomere shortening. Because studies of this phenomenon in VHL disease have been relatively scarce, we investigated anticipation in 18 Chinese VHL disease families. We recruited 34 parent–child patient pairs (57 patients) from 18 families with VHL disease. Onset age was defined as the age when any symptom or sign of VHL disease first appeared. Anticipation of onset age was analyzed by paired t test and the other two special tests (HV and RY2). Relative telomere length of peripheral leukocytes was measured in 29 patients and 325 healthy controls. Onset age was younger in child than in parent in 31 of the 34 parent–child pairs. Patients in the first generation had older onset age with longer age-adjusted relative telomere length, and those in the next generation had younger onset age with shorter age-adjusted relative telomere length (P < 0.001) in the 10 parent–child pairs from eight families with VHL disease. In addition, relative telomere length was shorter in the 29 patients with VHL disease than in the normal controls (P = 0.003). The anticipation may relate to the shortening of telomere length in patients with VHL in successive generations. These findings indicate that anticipation is present in families with VHL disease and may be helpful for genetic counseling for families with VHL disease families and for further understanding the pathogenesis of VHL disease. Cancer Res; 74(14); 3802–9. ©2014 AACR.

27 April 2016 in Oncology Letters
Verified
Journal Article
Open access
PDF file
XNXiang-Hui Ning
Xiang-Hui Ning
TLTeng Li
Teng Li
YGYan-Qing Gong
Yan-Qing Gong
QHQun He
Qun He
QSQi Shen
Qi Shen
KGKan Gong
Kan Gong
Fructose-1,6-bisphosphatase 1 (FBP1) is a rate-limiting enzyme in gluconeogenesis. Recently, the catalytic activity-independent function of FBP1, hypoxia-induced factor (HIF) repression in the nucleus, was identified. The aim of the present study was to investigate the association between FBP1 and hypoxia-related gene expression in clear cell renal cell carcinoma (ccRCC). The protein expression levels of FBP1, HIF-1α, HIF-2α, erythropoietin (EPO) and carbonic anhydrase IX (CA9) were assessed by immunohistochemical staining of ccRCC paraffin blocks from 123 patients using the tissue microarray technique. The expression level of FBP1 was then correlated with various clinicopathological factors, and the protein expression levels of HIF-1α, HIF-2α, EPO and CA9. Clinicopathological factors, including age, gender, T stage and Fuhrman grade, were not significantly different between patients with low and high FBP1 expression in ccRCC (P>0.05). FBP1 protein expression level was significantly correlated with the expression levels of HIF-1α (P=0.005) and EPO (P=0.010), but not significantly correlated with the expression levels of HIF-2α (P=0.123) and CA9 (P=0.513) in ccRCC tissues. The current findings confirm the association between FBP1 and hypoxia-related gene expression, and may facilitate understanding of the mechanisms of ccRCC tumorigenesis.

1 December 2016 in Oncotarget
Verified
Journal Article
Open access
PDF file
XNXiang-Hui Ning
Xiang-Hui Ning
YGYan-Qing Gong
Yan-Qing Gong
SHShi-Ming He
Shi-Ming He
TLTeng Li
Teng Li
JWJiang-Yi Wang
Jiang-Yi Wang
KGKan Gong
Kan Gong
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Xiang-hui Ning1, 2, 3, Yan-qing Gong1, 2, 3, Shi-ming He1, 2, 3, Teng Li1, 2, 3, Jiang-yi Wang1, 2, 3, Shuang-he Peng1, 2, 3, Jin-chao Chen1, 2, 3, Jia-yuan Liu1, 2, 3, Nie-nie Qi1, 2, 3, Ying-lu Guo1, 2, 3, Kan Gong1, 2, 3 1Department of Urology, Peking University First Hospital, Beijing 100034, P.R China 2Institute of Urology, Peking University, Beijing 100034, P.R China 3National Urological Cancer Center, Beijing 100034, P.R China Correspondence to: Ying-lu Guo, email: gyl07@sina.com Kan Gong, email: gongkan_pku@126.com Keywords: renal cell carcinoma, programmed death 1 ligand-1, prognosis, immune response Received: June 17, 2016 Accepted: November 22, 2016 Published: December 1, 2016

1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
XNXiang-Hui Ning
Xiang-Hui Ning
YQYuan-yuan Qi
Yuan-yuan Qi
FWFang-Xin Wang
Fang-Xin Wang
SLSong-Chao Li
Song-Chao Li
ZJZhan-Kui Jia
Zhan-Kui Jia
JYJin-Jian Yang
Jin-Jian Yang
Bladder cancer (BLCA) is the most common urinary tract tumor and is the 11th most malignant cancer worldwide. With the development of in‐depth multisystem sequencing, an increasing number of prognostic molecular markers have been identified. In this study, we focused on the role of protein‐coding gene methylation in the prognosis of BLCA. We downloaded BLCA clinical and methylation data from The Cancer Genome Atlas (TCGA) database and used this information to identify differentially methylated genes and construct a survival model using lasso regression. We assessed 365 cases, with complete information regarding survival status, survival time longer than 30 days, age, gender, and tumor characteristics (grade, stage, T, M, N), in our study. We identified 353 differentially methylated genes, including 50 hypomethylated genes and 303 hypermethylated genes. After annotation, a total of 227 genes were differentially expressed. Of these, 165 were protein‐coding genes. Three genes (zinc finger protein 382 (ZNF382), galanin receptor 1 (GALR1), and structural maintenance of chromosomes flexible hinge domain containing 1 (SMCHD1)) were selected for the final risk model. Patients with higher‐risk scores represent poorer survival than patients with lower‐risk scores in the training set (HR = 2.37, 95% CI 1.43‐3.94, p = 0.001), in the testing group (HR = 1.85, 95% CI 1.16‐2.94, p = 0.01), and in the total cohort (HR = 2.06, 95% CI 1.46‐2.90, p < 0.001). Further univariate and multivariate analyses using the Cox regression method were conducted in these three groups, respectively. All the results indicated that risk score was an independent risk factor for BLCA. Our study screened the different methylation protein‐coding genes in the BLCA tissues and constructed a robust risk model for predicting the outcome of BLCA patients. Moreover, these three genes may function in the mechanism of development and progression of BLCA, which should be fully clarified in the future.

14 November 2020 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
YQYuan-yuan Qi
Yuan-yuan Qi
YZYa-Fei Zhao
Ya-Fei Zhao
YZYa-Ling Zhai
Ya-Ling Zhai
XZXiao-Xue Zhang
Xiao-Xue Zhang
XWXiao-Yang Wang
Xiao-Yang Wang
ZZZhanzheng Zhao
Zhanzheng Zhao
Background. Systemic lupus erythematosus (SLE) is a complex autoimmune disease with strong genetic disposition with more than 100 susceptibility genes identified until now. However, our knowledge on SLE genetic background is still limited. The present study was aimed at evaluating the role of single nucleotide polymorphisms (SNPs) in SCUBE3, a TGF-β signaling activator, with SLE susceptibility in Chinese populations. Methods. A total of 2801 individuals (490 cases and 493 controls from GWAS cohort and 1003 cases and 815 controls from our cohort) were enrolled, and SNPs located 10 kb up- and downstream of SCUBE3 (chr6:35182190-35218609) were included in the genetic association study. Multiple layers of bioinformatics were conducted, and the levels of SCUBE3 expression were confirmed. Results. Of the 31 SNPs in SCUBE3 tested, 24 SNPs were significantly associated with SLE at . The top locus was rs1888822 with in the discovery cohort and was confirmed by the replication cohort with . Additionally, the levels of SCUBE3 mRNA expression were significantly lower in patients with SLE comparing with healthy controls ( ). Further expression data from ArrayExpress showed that the expression of SCUBE3 was also lower in CD3+ T cells and B cells from patients with SLE. Conclusions. Our research revealed that variants in SCUBE3, which encode SCUBE3 as a TGF-β signaling activator, can be considered as a new genetic susceptibility factor for systemic lupus erythematosus. And the reduced mRNA expression of SCUBE3 was first reported in patients with SLE.